Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Antonia M.S. Müller"'
Autor:
Sebastian Stolz, Marco Roncador, Wiebke Rösler, Thorsten Zenz, Markus G. Manz, Antonia M.S. Müller, Corinne C. Widmer
Publikováno v:
Swiss Medical Weekly, Vol 152, Iss 2526 (2022)
AIM OF THE STUDY: Chimeric antigen receptor T (CAR-T) cells are a powerful form of immune-cell therapy for patients with relapsed/refractory B-cell lymphoma and acute B lymphoblastic leukaemia. CAR-T cells have been commercially available in Switzerl
Externí odkaz:
https://doaj.org/article/47fa44e394e64f378a4571b47cd5f13d
Publikováno v:
Haematologica, Vol 104, Iss 2 (2019)
Externí odkaz:
https://doaj.org/article/845ce8c130724a56861d1e1778710268
Autor:
Christian Koch, Giulia Montrasio, Benedikt Florian Scherr, Roman Schimmer, Christian M. Matter, Karl Philipp Bühler, Markus G. Manz, Antonia M.S. Müller
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a06f7c71ced166dd692a8c1ce1776d
https://doi.org/10.5167/uzh-231632
https://doi.org/10.5167/uzh-231632
Autor:
Josefine Ruder, María José Docampo, Jordan Rex, Simon Obahor, Reza Naghavian, Antonia M.S. Müller, Urs Schanz, Ilijas Jelcic, Roland Martin
Publikováno v:
Science Translational Medicine. 14
Autologous hematopoietic stem cell transplantation (aHSCT) is a highly effective treatment of multiple sclerosis (MS). It depletes autoreactive cells and subsequently renews adaptive immune cells. The possible proinflammatory potential of surviving T
Autor:
Michael R. Bishop, Michael Dickinson, Duncan Purtill, Pere Barba, Armando Santoro, Nada Hamad, Koji Kato, Anna Sureda, Richard Greil, Catherine Thieblemont, Franck Morschhauser, Martin Janz, Ian Flinn, Werner Rabitsch, Yok-Lam Kwong, Marie J. Kersten, Monique C. Minnema, Harald Holte, Esther H.L. Chan, Joaquin Martinez-Lopez, Antonia M.S. Müller, Richard T. Maziarz, Joseph P. McGuirk, Emmanuel Bachy, Steven Le Gouill, Martin Dreyling, Hideo Harigae, David Bond, Charalambos Andreadis, Peter McSweeney, Mohamed Kharfan-Dabaja, Simon Newsome, Evgeny Degtyarev, Rakesh Awasthi, Christopher del Corral, Giovanna Andreola, Aisha Masood, Stephen J. Schuster, Ulrich Jäger, Peter Borchmann, Jason R. Westin
Publikováno v:
New England Journal of Medicine, 386(7), 629-639. Massachussetts Medical Society
New England journal of medicine, 386(7), 629-639. Massachussetts Medical Society
Bishop, M R, Dickinson, M, Purtill, D, Barba, P, Santoro, A, Hamad, N, Kato, K, Sureda, A, Greil, R, Thieblemont, C, Morschhauser, F, Janz, M, Flinn, I, Rabitsch, W, Kwong, Y-L, Kersten, M J, Minnema, M C, Holte, H, Chan, E H L, Martinez-Lopez, J, Müller, A M S, Maziarz, R T, McGuirk, J P, Bachy, E, Gouill, S L, Dreyling, M, Harigae, H, Bond, D, Andreadis, C, McSweeney, P, Kharfan-Dabaja, M, Newsome, S, Degtyarev, E, Awasthi, R, del Corral, C, Andreola, G, Masood, A, Schuster, S J, Jäger, U, Borchmann, P & Westin, J R 2022, ' Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma ', New England Journal of Medicine, vol. 386, no. 7, pp. 629-639 . https://doi.org/10.1056/NEJMoa2116596
New England journal of medicine, 386(7), 629-639. Massachussetts Medical Society
Bishop, M R, Dickinson, M, Purtill, D, Barba, P, Santoro, A, Hamad, N, Kato, K, Sureda, A, Greil, R, Thieblemont, C, Morschhauser, F, Janz, M, Flinn, I, Rabitsch, W, Kwong, Y-L, Kersten, M J, Minnema, M C, Holte, H, Chan, E H L, Martinez-Lopez, J, Müller, A M S, Maziarz, R T, McGuirk, J P, Bachy, E, Gouill, S L, Dreyling, M, Harigae, H, Bond, D, Andreadis, C, McSweeney, P, Kharfan-Dabaja, M, Newsome, S, Degtyarev, E, Awasthi, R, del Corral, C, Andreola, G, Masood, A, Schuster, S J, Jäger, U, Borchmann, P & Westin, J R 2022, ' Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma ', New England Journal of Medicine, vol. 386, no. 7, pp. 629-639 . https://doi.org/10.1056/NEJMoa2116596
BACKGROUND: Patient outcomes are poor for aggressive B-cell non-Hodgkin's lymphomas not responding to or progressing within 12 months after first-line therapy. Tisagenlecleucel is an anti-CD19 chimeric antigen receptor T-cell therapy approved for dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d15c5a71064f7018247c023fe0a84bb
https://research.vumc.nl/en/publications/05692014-3989-41b0-9670-0dae99bc18df
https://research.vumc.nl/en/publications/05692014-3989-41b0-9670-0dae99bc18df
Autor:
Antonia M.S. Müller, Hans-Michael Kaltenbach, Dominik Vogt, Nathan Cantoni, Jörg Halter, J. Linnik, Georg Stussi, Jörg Stelling, Mohammedyaseen Syedbasha, Urs Schanz, Maja Weisser, Thomas Pabst, Yvonne Hollenstein, Sabine Ruosch-Girsberger, Lukas Kaufmann, Adrian Egli
Publikováno v:
The Journal of Infectious Diseases, 225 (8)
Linnik, Janina; Syedbasha, Mohammedyaseen; Kaltenbach, Hans-Michael; Vogt, Dominik; Hollenstein, Yvonne; Kaufmann, Lukas; Cantoni, Nathan; Ruosch-Girsberger, Sabine; Müller, Antonia M S; Schanz, Urs; Pabst, Thomas; Stüssi, Georg; Weisser, Maja; Halter, Jörg; Stelling, Jörg; Egli, Adrian (2022). Association of Host Factors With Antibody Response to Seasonal Influenza Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Patients. The journal of infectious diseases, 225(8), pp. 1482-1493. Oxford University Press 10.1093/infdis/jiab391
Linnik, Janina; Syedbasha, Mohammedyaseen; Kaltenbach, Hans-Michael; Vogt, Dominik; Hollenstein, Yvonne; Kaufmann, Lukas; Cantoni, Nathan; Ruosch-Girsberger, Sabine; Müller, Antonia M S; Schanz, Urs; Pabst, Thomas; Stüssi, Georg; Weisser, Maja; Halter, Jörg; Stelling, Jörg; Egli, Adrian (2022). Association of Host Factors With Antibody Response to Seasonal Influenza Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Patients. The journal of infectious diseases, 225(8), pp. 1482-1493. Oxford University Press 10.1093/infdis/jiab391
Background Influenza vaccination efficacy is reduced after hematopoietic stem cell transplantation (HSCT) and patient factors determining vaccination outcomes are still poorly understood. Methods We investigated the antibody response to seasonal infl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b68ed71afad0f52ef1bc95ebe5f0f662
Autor:
Urs Schanz, Jan Bögeholz, Antonia M.S. Müller, Norman F. Russkamp, Eugenia Haralambieva, Elise Gourri, C. M. Wilk, Markus G. Manz, Nicolas J. Mueller
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:581-592
Outbreaks of viral infections, such as measles, are regularly observed and pose a serious threat to recipients of allogeneic hematopoietic cell transplantation (HCT). The questions of how long cellular and humoral protective host immunity persists, a
Publikováno v:
European Heart Journal: Case Reports
Background Severe coronavirus disease 2019 (COVID-19) has been increasingly recognized as a multisystem disease. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can infect literally any cell type that expresses its target receptor angiot
Autor:
Antonia M.S. Müller, Sebastian M Stolz, Max J Rieger, Urs Schanz, Marina Bissig, Inga Hegemann, Rahel Schwotzer, Corinne C Widmer, Sabine Ludwig, Tobias M. Benoit, Markus G. Manz, Gayathri Nair
Publikováno v:
British journal of haematologyReferences. 194(5)